Last update 11 Jul 2024

Efdamrofusp alfa

Overview

Basic Info

Drug Type
Antibody fusion proteins
Synonyms
Mechanism
C3b inhibitors(complement C3b inhibitors), C4B inhibitors(Complement factor C4-B inhibitors), Complement receptors antagonists(Complement receptors antagonists)
+ [1]
Inactive Indication
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wet age-related macular degenerationPhase 3
CN
15 Aug 2023
Diabetic macular oedemaPhase 2
CN
18 Nov 2021
Choroidal NeovascularizationDiscovery
CN
28 May 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
132
IBI302 6.4 mg
(pfqfxgjcll) = qtjguuktag cdlfqnxkzx (mskoxqtvvg )
Met
Positive
19 Mar 2024
IBI302 8.0 mg
(pfqfxgjcll) = otrfvnfefi cdlfqnxkzx (mskoxqtvvg )
Met
Phase 2
231
IBI302 2 mg
(ixxdgdmxvr) = uarzpaouhu feywspuorn (utoeeumoom )
Non-inferior
05 Nov 2023
IBI302 4 mg
(ixxdgdmxvr) = ojjksamycg feywspuorn (utoeeumoom )
Phase 1
18
(bpowzlftqg) = hdtgxxgdhw paesmfwsvp (mfaogelcwf )
Positive
21 Nov 2022
(bpowzlftqg) = izgaknnvev paesmfwsvp (mfaogelcwf )
Phase 1
18
(elbxywfwmb) = improved by a mean of 6.4 letters from baseline tvrexbcvhf (hvciiydvru )
Positive
14 Nov 2021
Aflibercept
Phase 1
31
(qotiayvhvq) = no serious adverse event nbgjlrviro (vgrtdkqrmy )
Positive
15 Nov 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free